214 related articles for article (PubMed ID: 20111957)
1. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
3. IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells.
Kitaura H; Fujimura Y; Yoshimatsu M; Kohara H; Morita Y; Aonuma T; Fukumoto E; Masuyama R; Yoshida N; Takano-Yamamoto T
Calcif Tissue Int; 2011 Jul; 89(1):65-73. PubMed ID: 21611811
[TBL] [Abstract][Full Text] [Related]
4. IL-18 induces apoptosis of adherent bone marrow cells in TNF-alpha mediated osteoclast formation in synergy with IL-12.
Kitaura H; Tatamiya M; Nagata N; Fujimura Y; Eguchi T; Yoshida N; Nakayama K
Immunol Lett; 2006 Sep; 107(1):22-31. PubMed ID: 16875741
[TBL] [Abstract][Full Text] [Related]
5. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
[TBL] [Abstract][Full Text] [Related]
6. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
[TBL] [Abstract][Full Text] [Related]
7. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
8. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
9. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
11. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
[TBL] [Abstract][Full Text] [Related]
12. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17.
Yago T; Nanke Y; Ichikawa N; Kobashigawa T; Mogi M; Kamatani N; Kotake S
J Cell Biochem; 2009 Nov; 108(4):947-55. PubMed ID: 19728295
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
16. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
17. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
